Talphera (TLPH) Interest Coverage Ratio (QoQ) (2010 - 2022)
Powered by 
Analysis
Talphera (TLPH) Interest Coverage Ratio (QoQ) (2010 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 176.64% |
| Sep 30, 2022 | 41.57% |
| Jun 30, 2022 | -100.85% |
| Mar 31, 2022 | -31.75% |
| Dec 31, 2021 | -9.09% |
| Sep 30, 2021 | 1.62% |
| Jun 30, 2021 | -19.90% |
| Mar 31, 2021 | -10.96% |
| Dec 31, 2020 | -11.79% |
| Sep 30, 2020 | -39.94% |
| Jun 30, 2020 | 57.72% |
| Mar 31, 2020 | -2.74% |
| Dec 31, 2019 | -10.37% |
| Sep 30, 2019 | 38.83% |
| Jun 30, 2019 | 18.43% |
| Mar 31, 2019 | -36.99% |
| Dec 31, 2018 | -35.62% |
| Sep 30, 2018 | -44.46% |
| Jun 30, 2018 | 5.08% |
| Mar 31, 2018 | -18.60% |